Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil
Introduction: Standard treatment for pediatric patients with localized osteosarcoma includes high-dose methotrexate (HDMTX), and cure rates greater than 60% are observed. However, in adult patients, the toxicity profile limits the use of HDMTX and the drug is usually excluded from chemotherapy proto...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
2021-10-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.brazilianjournalofoncology.com.br/details/159/en-US/treatment-outcomes-for-adult-patients-with-localized-osteosarcoma-treated-with-chemotherapy-without-methotrexate-at-a-public-hospital-in-brazil |
| _version_ | 1827807068791242752 |
|---|---|
| author | Marilia Polo Minguete-e-Silva Renata Rodrigues da Cunha Colombo Bonadio Gustavo Matos Diego de Araújo Toloi Rodrigo Ramella Munhoz Mirella Nardo Daniel Rebolledo Luiz Filipe Marques Correa Andre Mathias Baptista Caroline Chaul de Lima Barbosa Zampieri Olavo Feher Veridiana Pires de Camargo |
| author_facet | Marilia Polo Minguete-e-Silva Renata Rodrigues da Cunha Colombo Bonadio Gustavo Matos Diego de Araújo Toloi Rodrigo Ramella Munhoz Mirella Nardo Daniel Rebolledo Luiz Filipe Marques Correa Andre Mathias Baptista Caroline Chaul de Lima Barbosa Zampieri Olavo Feher Veridiana Pires de Camargo |
| author_sort | Marilia Polo Minguete-e-Silva |
| collection | DOAJ |
| description | Introduction: Standard treatment for pediatric patients with localized osteosarcoma includes high-dose methotrexate (HDMTX), and cure rates greater than 60% are observed. However, in adult patients, the toxicity profile limits the use of HDMTX and the drug is usually excluded from chemotherapy protocols for this group. We aimed to evaluate the outcomes of adult patients with localized osteosarcoma treated with chemotherapy without methotrexate.
Methods: In this retrospective cohort, we evaluated adult patients with high-grade osteosarcoma who received chemotherapy treatment without methotrexate in a reference cancer center from 2007 to 2018. Outcomes analyzed were recurrence-free survival (RFS), overall survival (OS), and prognostic factors associated with overall survival.
Results: A total of 48 patients had localized disease and received treatment with chemotherapy without methotrexate. The majority of them received chemotherapy with a combination of cisplatin and doxorubicin (n=42, 87.5%). Median age was 27 years (range 16.8-66.7). With a median follow-up of 29.2 months, median RFS was 29.9 months. Median OS was not reached. 5-year RFS and OS rates were 35.1% (95% CI: 20.3-50.2%) and 71.6% (95% CI: 52.3-84.2%), respectively. Patients who received cumulative doses of doxorubicin ≥375mg/m2 had better OS than those who received lower doses (HR 0.26, 95% CI: 0.07-0.94, p=0.041). Similarly, patients who received ≥6 cycles of neoadjuvant/adjuvant cisplatin tended to have better OS than those who received <6 cycles (HR 0.30, 95% CI: 0.081.09, p=0.069). Nineteen patients received less than 6 cycles of cisplatin and doxorubicin mainly because of grade 3 or 4 toxicities (11), disease progression (6), patient refusal (1), and physician choice (1). Conclusion: In our study, adult patients with localized highgrade osteosarcoma treated with chemotherapy without methotrexate had unfavorable outcomes. The cumulative doxorubicin dose and the number of cisplatin/doxorubicin cycles were associated with improved OS. The investigation of additional treatment strategies is of utmost importance to improve adult patients’ outcomes. |
| first_indexed | 2024-03-11T21:51:45Z |
| format | Article |
| id | doaj.art-b3e315fb46224a8b96c7153c8f42e873 |
| institution | Directory Open Access Journal |
| issn | 2526-8732 |
| language | English |
| last_indexed | 2024-03-11T21:51:45Z |
| publishDate | 2021-10-01 |
| publisher | Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia |
| record_format | Article |
| series | Brazilian Journal of Oncology |
| spelling | doaj.art-b3e315fb46224a8b96c7153c8f42e8732023-09-26T09:00:16ZengSociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de RadioterapiaBrazilian Journal of Oncology2526-87322021-10-01170010.5935/2526-8732.20210012Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in BrazilMarilia Polo Minguete-e-Silva0Renata Rodrigues da Cunha Colombo Bonadio1Gustavo Matos2Diego de Araújo Toloi3Rodrigo Ramella Munhoz4Mirella Nardo5Daniel Rebolledo6Luiz Filipe Marques Correa7Andre Mathias Baptista8Caroline Chaul de Lima Barbosa Zampieri9Olavo Feher10Veridiana Pires de Camargo11Instituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilInstituto Do Cancer Do Estado De Sao Paulo, Clinical Oncology - Sao Paulo - Sao Paulo - BrazilIntroduction: Standard treatment for pediatric patients with localized osteosarcoma includes high-dose methotrexate (HDMTX), and cure rates greater than 60% are observed. However, in adult patients, the toxicity profile limits the use of HDMTX and the drug is usually excluded from chemotherapy protocols for this group. We aimed to evaluate the outcomes of adult patients with localized osteosarcoma treated with chemotherapy without methotrexate. Methods: In this retrospective cohort, we evaluated adult patients with high-grade osteosarcoma who received chemotherapy treatment without methotrexate in a reference cancer center from 2007 to 2018. Outcomes analyzed were recurrence-free survival (RFS), overall survival (OS), and prognostic factors associated with overall survival. Results: A total of 48 patients had localized disease and received treatment with chemotherapy without methotrexate. The majority of them received chemotherapy with a combination of cisplatin and doxorubicin (n=42, 87.5%). Median age was 27 years (range 16.8-66.7). With a median follow-up of 29.2 months, median RFS was 29.9 months. Median OS was not reached. 5-year RFS and OS rates were 35.1% (95% CI: 20.3-50.2%) and 71.6% (95% CI: 52.3-84.2%), respectively. Patients who received cumulative doses of doxorubicin ≥375mg/m2 had better OS than those who received lower doses (HR 0.26, 95% CI: 0.07-0.94, p=0.041). Similarly, patients who received ≥6 cycles of neoadjuvant/adjuvant cisplatin tended to have better OS than those who received <6 cycles (HR 0.30, 95% CI: 0.081.09, p=0.069). Nineteen patients received less than 6 cycles of cisplatin and doxorubicin mainly because of grade 3 or 4 toxicities (11), disease progression (6), patient refusal (1), and physician choice (1). Conclusion: In our study, adult patients with localized highgrade osteosarcoma treated with chemotherapy without methotrexate had unfavorable outcomes. The cumulative doxorubicin dose and the number of cisplatin/doxorubicin cycles were associated with improved OS. The investigation of additional treatment strategies is of utmost importance to improve adult patients’ outcomes.http://www.brazilianjournalofoncology.com.br/details/159/en-US/treatment-outcomes-for-adult-patients-with-localized-osteosarcoma-treated-with-chemotherapy-without-methotrexate-at-a-public-hospital-in-brazilosteosarcomaantineoplastic agentsdoxorubicinmethotrexate |
| spellingShingle | Marilia Polo Minguete-e-Silva Renata Rodrigues da Cunha Colombo Bonadio Gustavo Matos Diego de Araújo Toloi Rodrigo Ramella Munhoz Mirella Nardo Daniel Rebolledo Luiz Filipe Marques Correa Andre Mathias Baptista Caroline Chaul de Lima Barbosa Zampieri Olavo Feher Veridiana Pires de Camargo Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil Brazilian Journal of Oncology osteosarcoma antineoplastic agents doxorubicin methotrexate |
| title | Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil |
| title_full | Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil |
| title_fullStr | Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil |
| title_full_unstemmed | Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil |
| title_short | Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil |
| title_sort | treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in brazil |
| topic | osteosarcoma antineoplastic agents doxorubicin methotrexate |
| url | http://www.brazilianjournalofoncology.com.br/details/159/en-US/treatment-outcomes-for-adult-patients-with-localized-osteosarcoma-treated-with-chemotherapy-without-methotrexate-at-a-public-hospital-in-brazil |
| work_keys_str_mv | AT mariliapolomingueteesilva treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT renatarodriguesdacunhacolombobonadio treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT gustavomatos treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT diegodearaujotoloi treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT rodrigoramellamunhoz treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT mirellanardo treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT danielrebolledo treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT luizfilipemarquescorrea treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT andremathiasbaptista treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT carolinechauldelimabarbosazampieri treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT olavofeher treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil AT veridianapiresdecamargo treatmentoutcomesforadultpatientswithlocalizedosteosarcomatreatedwithchemotherapywithoutmethotrexateatapublichospitalinbrazil |